BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

GC Cell Secures Exclusive Rights to DAAN Biotherapeutics’ Tumor Antigen-Specific Antibody for CAR-T and CAR-NK Therapies

DAAN Biotherapeutics, a leading innovative drug development company specializing in T-Cell receptor (TCR)-based therapies, has signed an exclusi...

April 22, 2025 | News

WuXi Biologics Achieves Asia’s First Commercial PPQ Milestone with 3 x 5,000L Single-Use Bioreactors

- The campaign marks the successful commercial-scale PPQ completion of Asia's first 3 X 5,0...

April 21, 2025 | News

Earendil Labs and Sanofi Sign $1.72B Licensing Deal for AI-Discovered Bispecific Antibodies Targeting Autoimmune and Inflammatory Bowel Diseases

Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, and Sanofi announced that they have entered...

April 18, 2025 | News

VelaVigo Bio Signs $440M Global Licensing Deal with Ollin Biosciences for First-in-Class Bispecific Antibody VBS-102

VelaVigo Bio, the U.S. subsidiary of VelaVigo Cayman Limited (VelaVigo), a biotech company with a robust discovery and development platform of multi-specif...

April 18, 2025 | News

TGA Approves IFINWIL® for High-Risk Neuroblastoma Treatment in Australia

Norgine is pleased to announce that the Australian Therapeutic Goods Administration (TGA) has approved the registration of IFINWIL® (eflornit...

April 17, 2025 | Regulatory

Atmo Biosciences Secures Full Ownership of Core IP for Ingestible Gas-Sensing Capsule

Atmo secures full ownership of core IP for its ingestible gas-sensing capsule • RMIT University transfers all patents and IP in exchange for an eq...

April 15, 2025 | News

Chromatin Bioscience Partners with Astellas to Advance Cell-Selective Gene Expression Technologies

Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement with As...

April 15, 2025 | News

Thermo Fisher Launches 5L DynaDrive Single-Use Bioreactor to Accelerate Scalable Bioprocessing

Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the 5L DynaDrive™ Single-Use Bioreactor (S.U.B.), designed to meet...

April 15, 2025 | News

Nona Biosciences Partners with Atossa Therapeutics to Advance Next-Generation Antibody Therapies for Breast Cancer

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), ranging from target validation and antibody ...

April 11, 2025 | News

Singapore’s Engine Biosciences and EDDC Launch First-Ever Partnership to Advance Precision Cancer Therapies

This marks the first-ever collaboration between Engine Biosciences and Experimental Drug Development Centre (EDDC),&nb...

April 08, 2025 | News

IRBM Launches Advanced Functional Genomics Platform to Power Precision Target Discovery and Validation

IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Pl...

April 03, 2025 | News

Thermo Fisher Scientific Launches Krios 5 Cryo-TEM, Setting New Standard in Atomic-Resolution Imaging

Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Krios™ 5 Cryo-TEM. This next-generati...

April 03, 2025 | News

Telix Doses First Patient in ZOLAR Phase 1 Trial for Advanced Soft Tissue Sarcoma

Telix Pharmaceuticals Limited announces that a first patient has been dosed in the Phase 1 ZOLAR trial of TLX300-CDx (89Zr-olaratumab) in patients wit...

April 02, 2025 | News

How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market

In this exclusive email interaction with BioPharma APAC, Alessandra Ambruosi, Director & Head of Solid Formulations & Pharm Materia...

April 02, 2025 | Interview

Stay Connected